Shares of Zogenix (ZGNX), a small-cap pharmaceutical company with a focus on disorders of the central never system, fell hard during the month of September.
Was the sell-off justified? Read the short presentation below to get all of the details.
The next billion-dollar iSecret
The world's biggest tech company forgot to show you something at its recent event, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early, in-the-know investors! To be one of them, just click here.
